OrbiMed’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-210,287
| Closed | -$93.6M | – | 131 |
|
|
2025
Q2 | $93.6M | Buy |
210,287
+50,387
| +32% | +$23.2M | 2.35% | 14 |
|
|
2025
Q1 | $77.5M | Buy |
159,900
+8,900
| +6% | +$4.15M | 1.86% | 16 |
|
|
2024
Q4 | $60.8M | Hold |
151,000
| – | – | 1.26% | 26 |
|
|
2024
Q3 | $70.2M | Hold |
151,000
| – | – | 1.29% | 24 |
|
|
2024
Q2 | $70.8M | Buy |
151,000
+28,300
| +23% | +$12.3M | 1.41% | 21 |
|
|
2024
Q1 | $51.3M | Sell |
122,700
-52,500
| -30% | -$22.2M | 0.94% | 38 |
|
|
2023
Q4 | $71.3M | Buy |
175,200
+9,800
| +6% | +$3.62M | 1.43% | 25 |
|
|
2023
Q3 | $57.5M | Hold |
165,400
| – | – | 1.23% | 28 |
|
|
2023
Q2 | $58.2M | Sell |
165,400
-12,200
| -7% | -$4.11M | 1.06% | 37 |
|
|
2023
Q1 | $56M | Sell |
177,600
-93,900
| -35% | -$28.2M | 1.11% | 30 |
|
|
2022
Q4 | $78.4M | Sell |
271,500
-101,700
| -27% | -$31M | 1.5% | 20 |
|
|
2022
Q3 | $108K | Sell |
373,200
-14,000
| -4% | -$4.03M | 2.01% | 11 |
|
|
2022
Q2 | $109K | Sell |
387,200
-13,000
| -3% | -$3.48M | 1.99% | 14 |
|
|
2022
Q1 | $104M | Sell |
400,200
-257,900
| -39% | -$61.2M | 1.7% | 20 |
|
|
2021
Q4 | $145M | Sell |
658,100
-219,300
| -25% | -$42.6M | 1.86% | 13 |
|
|
2021
Q3 | $159M | Sell |
877,400
-188,000
| -18% | -$36.7M | 1.75% | 14 |
|
|
2021
Q2 | $215M | Sell |
1,065,400
-70,500
| -6% | -$14.7M | 2.18% | 12 |
|
|
2021
Q1 | $244M | Buy |
1,135,900
+301,800
| +36% | +$66.3M | 2.29% | 11 |
|
|
2020
Q4 | $197M | Buy |
834,100
+168,000
| +25% | +$38.5M | 1.73% | 15 |
|
|
2020
Q3 | $181M | Hold |
666,100
| – | – | 2.29% | 13 |
|
|
2020
Q2 | $193M | Sell |
666,100
-71,300
| -10% | -$19.3M | 2.73% | 7 |
|
|
2020
Q1 | $175M | Sell |
737,400
-45,700
| -6% | -$10.5M | 2.97% | 7 |
|
|
2019
Q4 | $171M | Sell |
783,100
-63,300
| -7% | -$12.8M | 2.46% | 11 |
|
|
2019
Q3 | $143M | Sell |
846,400
-126,900
| -13% | -$22.4M | 2.75% | 9 |
|
|
2019
Q2 | $178M | Buy |
973,300
+18,000
| +2% | +$3.15M | 2.82% | 8 |
|
|
2019
Q1 | $176M | Sell |
955,300
-177,900
| -16% | -$32.9M | 2.75% | 8 |
|
|
2018
Q4 | $188M | Sell |
1,133,200
-467,300
| -29% | -$81M | 3.51% | 8 |
|
|
2018
Q3 | $308M | Sell |
1,600,500
-192,100
| -11% | -$34.2M | 3.73% | 4 |
|
|
2018
Q2 | $305M | Sell |
1,792,600
-62,000
| -3% | -$9.61M | 3.66% | 5 |
|
|
2018
Q1 | $302M | Buy |
1,854,600
+113,300
| +7% | +$18.5M | 3.77% | 3 |
|
|
2017
Q4 | $261M | Sell |
1,741,300
-333,002
| -16% | -$49.3M | 3.31% | 5 |
|
|
2017
Q3 | $315M | Buy |
2,074,302
+47,800
| +2% | +$7.19M | 3.03% | 6 |
|
|
2017
Q2 | $261M | Sell |
2,026,502
-142,698
| -7% | -$17.2M | 2.75% | 6 |
|
|
2017
Q1 | $237M | Buy |
2,169,200
+9,800
| +0.5% | +$863K | 2.7% | 9 |
|
|
2016
Q4 | $159M | Buy |
2,159,400
+547,400
| +34% | +$44.5M | 2.04% | 16 |
|
|
2016
Q3 | $141M | Sell |
1,612,000
-577,300
| -26% | -$54.6M | 1.61% | 22 |
|
|
2016
Q2 | $188M | Buy |
2,189,300
+319,900
| +17% | +$27.6M | 1.99% | 14 |
|
|
2016
Q1 | $149M | Buy |
1,869,400
+1,196,400
| +178% | +$108M | 1.57% | 19 |
|
|
2015
Q4 | $84.7M | Buy |
673,000
+558,000
| +485% | +$67.4M | 0.77% | 40 |
|
|
2015
Q3 | $12M | Hold |
115,000
| – | – | 0.12% | 88 |
|
|
2015
Q2 | $14.2M | Sell |
115,000
-20,000
| -15% | -$2.52M | 0.12% | 93 |
|
|
2015
Q1 | $15.9M | Sell |
135,000
-1,596,200
| -92% | -$191M | 0.14% | 87 |
|
|
2014
Q4 | $206M | Buy |
1,731,200
+381,200
| +28% | +$42.9M | 2% | 18 |
|
|
2014
Q3 | $152M | Buy |
1,350,000
+822,000
| +156% | +$78.3M | 1.67% | 26 |
|
|
2014
Q2 | $50M | Buy |
528,000
+368,000
| +230% | +$25.8M | 0.6% | 45 |
|
|
2014
Q1 | $11.3M | Sell |
160,000
-95,000
| -37% | -$7.52M | 0.14% | 86 |
|
|
2013
Q4 | $18.9M | Sell |
255,000
-83,000
| -25% | -$5.78M | 0.28% | 65 |
|
|
2013
Q3 | $25.6M | Buy |
338,000
+115,000
| +52% | +$9.15M | 0.47% | 48 |
|
|
2013
Q2 | $17.9M | Buy |
+223,000
| New | +$16.4M | 0.4% | 53 |
|
Other funds holding VRTX
